United States COVID-19 Sample Collection Kits Market is estimated to reach USD 0.11 billion by 2033 | Top Companies - Thermo Fisher Scientific Inc., VIRCELL S.L., Puritan Medical Products

Market Size and Growth:

The COVID-19 Sample Collection Kits Market Size was valued at USD 7.2 billion in 2024 and is estimated to reach USD 9.6 billion by 2033, growing at a CAGR of 2.94% during the forecast period (2025-2033). The Market is growing due to the ongoing need for reliable diagnostic preparedness, expansion of infectious disease surveillance, and rising investment in public health infrastructure worldwide.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/covid-19-sample-collection-kits-market?sz

The COVID-19 Sample Collection Kits Market refers to the industry that produces and supplies kits used to collect respiratory or biological specimens for COVID-19 testing. These kits include swabs, transport media, and containers designed to preserve sample integrity. The market supports diagnostic labs, hospitals, and point-of-care settings by enabling accurate virus detection, surveillance, and large-scale testing during outbreaks and routine monitoring.

Industry Recent Developments: United States

✅ October 2025: Advancements in diagnostic technologies are driving growth with new home collection kits and antigen tests, supported by government collaborations to enhance testing capacity.

✅ November 2025: Introduction of improved swab designs and blood collection kits approved by regulatory authorities to enhance accuracy and facilitate broader testing applications in clinical settings.

✅ December 2025: Continued rise in demand for sample collection kits driven by emerging virus variants and ongoing need for respiratory disease surveillance, with expansion of home-based testing methods.

Industry Recent Developments: Japan

✅ October 2025: Strategic partnerships formed between diagnostic companies and government agencies to boost production and distribution of sample collection kits, addressing supply shortages.

✅ November 2025: Growing adoption of AI-enabled smart sample collection tools that enhance diagnostic precision, reduce turnaround times, and improve regulatory compliance in line with Ministry of Health guidelines.

✅ December 2025: Shift towards rapid and decentralized testing solutions, including increased use of nasal swab self-collection kits for faster and more convenient sample collection.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/covid-19-sample-collection-kits-market?sz

Key FDA / U.S. Regulatory Activity (2025):

✅ The FDA continues to administer SARS-CoV-2 device authorizations through its EUA framework and maintains updated tables of authorized molecular and antigen tests - these listings also record authorized sample collection attributes (e.g., anterior nasal swab, nasopharyngeal swab, saliva, self-collection). See FDA EUA pages for molecular and antigen tests.

✅ Examples of authorized collection-kit products still in the ecosystem include programs like SalivaDirect (DTC saliva collection kits intended to be sent to an authorized lab) - FDA fact sheets and product pages remain the primary source for product-specific conditions. (SalivaDirect fact sheet).

✅ The FDA's continuing OTC authorizations for at-home COVID tests (where users collect their own sample) mean sample-collection components and packaging remain under active regulatory oversight even as overall demand fluctuates.

Major 2025 Mergers & Acquisitions:

✅ Becton, Dickinson & Co. (BD) - Waters deal (announced 2025): BD said it would combine its Biosciences & Diagnostic Solutions division with Waters Corporation in a ~$17.5B Reverse Morris Trust transaction. That transaction reshapes BD's diagnostics footprint (BD is a major diagnostics / specimen-handling player), so it has direct implications for distribution, product bundling and R&D in specimen collection/transport. (Reuters coverage).

✅ Thermo Fisher Scientific - Clario acquisition (announced 2025): Thermo Fisher announced a large acquisition of clinical trial software company Clario (up to $9.4B). While this isn't a swab maker buy, Thermo Fisher's scale across sample logistics, diagnostics consumables and lab services links this deal to broader sample-handling and clinical-trial collection ecosystems. (Financial Times).

✅ Medline and others - strategic moves/IPO talk: Medline (large medical-supplies manufacturer and distributor that touches supply chains for collection kits and PPE) was actively positioning via acquisitions and IPO planning in 2025 - a move that can influence procurement and manufacturing scale for collection consumables.

Major Key Players:

1. Thermo Fisher Scientific Inc.
A global leader in laboratory instruments, reagents, diagnostics and life-science services serving research, clinical and industrial markets.
Known for broad product breadth, strong global distribution, and integrated solutions (instruments + consumables + services).

2. VIRCELL S.L.
A specialized biotechnology company focused on diagnostic solutions for infectious diseases and serology (including viral antigens and assay development).
Valued for niche expertise in virology reagents and custom assay development used by labs and vaccine researchers.

3. Puritan Medical Products
A major manufacturer of medical swabs, specimen collection devices and transport products used by clinical and public-health testing programs.
Competitive advantage comes from high-volume manufacturing capacity and regulatory-compliant production for large testing campaigns.

4. HiMedia Laboratories
An India-based microbiology company producing culture media, reagents and lab consumables for clinical, pharmaceutical and food testing.
Known for cost-competitive products, deep regional distribution in Asia, and wide catalog for microbiology labs.

5. Medline Industries, Inc.
A large healthcare supply company providing medical disposables, procedural kits, and logistics solutions to hospitals and long-term care.
Strengths include scale, supply-chain integration, and customized bundled product programs for healthcare providers.

6. COPAN Diagnostics
Specializes in specimen collection systems, transport media and automated microbiology solutions for clinical and molecular diagnostics.
Recognized for innovation in sample collection/transport (e.g., flocked swabs) and close partnerships with diagnostic labs.

Segments Covered in the COVID-19 Sample Collection Kits Market:

By Product Type: Swabs, Blood Collection Kits, Viral Transport Media, Others Consumables.

By End-Users: Hospitals & Clinic, Home Test.

Regional Analysis for COVID-19 Sample Collection Kits Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=covid-19-sample-collection-kits-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, COVID-19 Sample Collection Kits market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global COVID-19 Sample Collection Kits Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global COVID-19 Sample Collection Kits market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the COVID-19 Sample Collection Kits Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of COVID-19 Sample Collection Kits market?

➠ Who are the global key manufacturers of the COVID-19 Sample Collection Kits Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the COVID-19 Sample Collection Kits market opportunities and threats faced by the vendors in the global COVID-19 Sample Collection Kits Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the COVID-19 Sample Collection Kits market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.